Individual compound profiles — mechanism of action, research summary, typical research doses, and how each compound compares to alternatives.
What Semax is, how intranasal nootropic research frames it, Semax vs Selank, Australian research-supply rules, purity standards, and literature dosing ranges.
Standalone TB-500 research guide — actin-binding mechanism, tissue-repair models, handling, Australian supply framing, and how it differs from BPC-157.
MOTS-c explained for Australian researchers — mitochondrial-derived peptide biology, metabolic study themes, handling, stacks, and research-use supply standards.
Selank research guide for Australia — tuftsin-derived heptapeptide, vs Semax, intranasal delivery, legality framing, purity standards, and catalogue links.
PT-141 (bremelanotide) research overview — melanocortin pathway, vs Melanotan-2, delivery routes, Australian research-supply framing, and quality standards.
Retatrutide as a GLP-1/GIP/glucagon tri-agonist research peptide — how it differs from tirzepatide and semaglutide literature, research-only framing, handling, and AU compliance.
NAD+ research guide — redox cofactor biology, aging literature themes, vs NMN/NR precursors, handling, and Australian research-supply standards.
Epithalon (Epitalon) research guide — tetrapeptide longevity literature, telomerase themes, spelling variants, handling, and AU research-use supply.
Peptide therapy, compounded peptides, registered medicines, and research peptides — three Australian pathways often confused for one. How to self-route to the correct one.
Intranasal peptides for research — Semax, Selank, PT-141, and the nose-to-brain delivery literature. What the absorption research shows and the Australian regulatory frame.
BPC-157 capsules vs injection — why this peptide is unusual for oral delivery, what the research compares, and the format-choice framework for research protocols.
Are peptides steroids? No — they're structurally and mechanistically different molecules. The amino-acid vs steroid-nucleus distinction, receptor pathways, and side-effect profiles.
What the melanocortin peptide research literature documents — Melanotan I, Melanotan II, PT-141. Receptor selectivity, regulatory status in Australia, honest research framing.
Thymosin Alpha 1 research — T-cell maturation, dendritic cell activation, viral infection adjunct studies. How it differs from Thymosin Beta 4 / TB-500.
Sermorelin, CJC-1295, and Tesamorelin compared — half-life, mechanism, research applications, Australian regulatory status, and which GHRH analogue suits which research.
Wolverine stack, Glow stack, and other named peptide combinations — the research-framework explanation for each, and the compounds that make them up.
Peptides for hair growth research — GHK-Cu, BPC-157, the hair-cycle biology, cosmetic-vs-research pathways, and dual regulatory framework in Australia.
Anti-aging peptides for longevity research — Epithalon, NAD+, SS-31, MOTS-c, GHK-Cu, GH-axis compounds. Mechanisms behind aging-biology research framing.
SARMs vs peptides — different molecules, different mechanisms, different regulatory categories. Honest comparison for Australian research contexts.
Peptides for skin research — GHK-Cu, Argireline, matrixyl, BPC-157. What dermal-pathway peptides do, dual regulatory pathways, and Australian research supply.
GHK-Cu copper peptide research guide — mechanism, dermal collagen synthesis, hair-follicle research, dosing, side effects, and Australian regulatory context.
What pre-clinical and clinical research literature documents about research peptide safety — BPC-157, GH secretagogues, GHK-Cu, incretin compounds.
Are peptides legal in Australia? A clear walk-through of the four regulatory categories — prescription, compounded, research-grade, and cosmetic — for AU researchers.
Growth hormone peptides — CJC-1295, Ipamorelin, Tesamorelin, and HGH. How GHRH analogues and ghrelin agonists are studied together in GH-axis research.
TB-500 vs BPC-157 — the mechanisms, where they differ, and why most research protocols stack them. Lab-verified ≥99% purity, Australian-shipped.
What the BPC-157 research actually shows — mechanism, dosing, side effects, legal status in Australia, and how the literature frames this research peptide.
